$3.66
-0.01[-0.27%]
At close: May 29
$3.66
0[0.00%]
PreMarket: 4:25AM EDT
CureVac
(NASDAQ:CVAC)Latest News for CureVac Stock (NASDAQ:CVAC)
CureVac Stock (NASDAQ: CVAC)
Categories: All
Thursday, May 23, 2024
- CureVac's Cash And Cash Equivalents Position Of €300.2M As Of March 31, 2024; Reaffirming Cash Runway Into Fourth Quarter Of 2025Benzinga Newsdesk - 5 days ago
- CureVac Reported Q1 2024 Pre-Tax Loss Of €69.9M Vs. €57.4M YoYBenzinga Newsdesk - 5 days ago
- CureVac Q1 2024 Sales €12.400M Beat €12.030M EstimateBenzinga Newsdesk - 5 days ago
Wednesday, May 22, 2024
Friday, May 17, 2024
Thursday, May 09, 2024
Monday, May 06, 2024
Friday, April 26, 2024
Thursday, April 25, 2024
- CureVac shares are trading lower after Leerink Partners downgraded the stock from Outperform to Market Perform and lowered its price target from $12 to $4.Benzinga Newsdesk - Apr 25, 2024, 11:29AM
- Leerink Partners Downgrades CureVac to Market Perform, Lowers Price Target to $4Benzinga Newsdesk - Apr 25, 2024, 9:12AM
Wednesday, April 24, 2024
- CureVac shares are trading lower after the company reported Q4 financial results and provided business updates.Benzinga Newsdesk - Apr 24, 2024, 10:35AM
- CureVac Has Started The Phase 1 Part Of A Combined Phase 1/2 Study Of An Investigational Influenza A (H5N1) Pre-Pandemic Vaccine Candidate Developed In Collaboration With GSK, H5N1 Is An Avian Influenza VirusBenzinga Newsdesk - Apr 24, 2024, 7:20AM
- CureVac And GSK Will End The Pandemic Preparedness Agreement Jointly Concluded With The Federal Republic Of Germany In April 2022, After Consultation With The German Federal Ministry Of HealthBenzinga Newsdesk - Apr 24, 2024, 7:18AM
- CureVac Is Implementing In 2024 An Organizational Redesign To Streamline Structures And Reduce Operating Costs. The Program Was Initiated With A "Voluntary Leaver" Program, To Reduce 150 PositionBenzinga Newsdesk - Apr 24, 2024, 7:17AM
- CureVac's Cash And Cash Equivalents Position Of €402.5M As Of December 31, 2023 Is Expected To Provide Cash Runway Into Q4 2025Benzinga Newsdesk - Apr 24, 2024, 7:16AM
- CureVac Q4 Sales €22.600M Miss €33.744M EstimateBenzinga Newsdesk - Apr 24, 2024, 7:15AM
Tuesday, April 16, 2024
Friday, April 12, 2024
Friday, April 05, 2024
Thursday, April 04, 2024
Wednesday, January 17, 2024
Friday, January 05, 2024
- Why Biopharmaceutical Player CureVac Shares Are Rising TodayNabaparna Bhattacharya - Jan 5, 2024, 10:31AM
- CureVac Unveils Positive Phase 2 Interim Data From COVID-19 Vaccine Development Program In Collaboration With GSK Providing Strong Validation of Proprietary Technology PlatformBenzinga Newsdesk - Jan 5, 2024, 7:08AM
Tuesday, December 19, 2023
- Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionAvi Kapoor - Dec 19, 2023, 1:34PM
- CureVac shares are trading lower after the company announced the nullity action filed by BioNTech SE against the German part of CureVac patent EP 1 857 122 B1 was granted by the German Federal Patent Court.Benzinga Newsdesk - Dec 19, 2023, 10:55AM
- Why Is COVID-19 Vaccine Player CureVac Stock Plummeting Today?Vandana Singh - Dec 19, 2023, 10:31AM
- Bluebird Bio, Vertex Energy And Other Big Stocks Moving Lower On TuesdayAvi Kapoor - Dec 19, 2023, 10:19AM
- CureVac Announces Decision Of German Federal Patent Court In Broad Patent Litigation With BioNTech SEBenzinga Newsdesk - Dec 19, 2023, 9:39AM
- German Patent Court Invalidates CureVac Patent On mRNA After Challenge Brought By BioNTechBenzinga Newsdesk - Dec 19, 2023, 8:39AM
Wednesday, November 15, 2023
Tuesday, November 14, 2023
Wednesday, November 01, 2023
Thursday, September 28, 2023
- Stocks That Hit 52-Week Lows On ThursdayBenzinga Insights - Sep 28, 2023, 2:32PM
- Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Sep 28, 2023, 1:04PM
- CureVac shares are trading lower after the company announced the Regional Court Düsseldorf has decided to suspend proceedings on four intellectual property rights in the infringement lawsuit filed by CureVac against BioNTech.Benzinga Newsdesk - Sep 28, 2023, 10:36AM
- Curevac Announced Regional Court Düsseldorf Popstpones Infringement Ruling On Four Intellectual Property Rights In Lawsuit Filed By CureVac Against BioNTechCharles Gross - Sep 28, 2023, 7:06AM
Tuesday, September 12, 2023
Monday, August 21, 2023
Wednesday, August 16, 2023
Tuesday, June 27, 2023
Tuesday, June 20, 2023
- CureVac Option Alert: Jul 21 $12.5 Calls Sweep (5) near the Ask: 574 @ $0.9 vs 1353 OI; Earnings 8/17 Before Open [est] Ref=$11.605Charles Gross - Jun 20, 2023, 12:25PM
- CureVac shares are trading higher after the company dosed the first patient in its Phase 1 study of its cancer vaccine candidate for surgically resected glioblastoma.Benzinga Newsdesk - Jun 20, 2023, 11:09AM
- DICE Therapeutics, Surmodics, Nikola, And Other Big Stocks Moving Higher On TuesdayLisa Levin - Jun 20, 2023, 10:22AM
- CureVac Option Alert: Jul 21 $10 Calls Sweep (19) above Ask!: 400 @ $1.793 vs 1337 OI; Earnings 8/17 Before Open [est] Ref=$11.1Charles Gross - Jun 20, 2023, 10:17AM
- CureVac Doses First Patient In Phase 1 Study Of Cancer Vaccine Candidate For Surgically Resected GlioblastomaBenzinga Newsdesk - Jun 20, 2023, 7:26AM